Table 3 The top 10 genes with significantly altered expression (FDR < 0.1) in CPM samples compared with primary CRC samples.

From: The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with an increased tumour mutational burden

Rank

Gene name

Function

Fold change

FDR p value

Reduced expression CPM samples vs. primary CRC

1

FABP6

Intracellular bile acid transporter

− 34.30

1.74 × 10–06

2

DEFA6

Cytotoxic peptide involved in host intestine defence

− 8.15

8.55 × 10–06

3

DMBT1

Tumour suppressor

− 6.06

2.43 × 10–04

4

TTC38

Protein coding gene

− 4.56

5.80 × 10–05

5

OLFM4

Wnt/β-catenin pathway target

− 3.77

1.01 × 10–04

6

IGHA1

Immune receptor

− 3.66

4.23 × 10–05

7

CES2

Intestinal enzyme controlling drug clearance

− 3.20

6.84 × 10–05

8

NDUFS6

Enzyme in electron transport chain of mitochondria

− 2.70

7.74 × 10–05

9

P2RY11

G-protein coupled receptor

− 2.53

6.37 × 10–04

10

MUC2

Encodes a mucinous intestinal coating

− 2.34

7.22 × 10–04

Increased expression CPM samples vs. primary CRC

1

CD53

Tetraspanin

7.29

5.87 × 10–05

2

CYR61

Extracellular signalling protein

4.24

3.12 × 10–04

3

CXCL12

G-protein coupled receptor

3.64

9.25 × 10–04

4

NR2F1

Nuclear hormone receptor and transcriptional regulator

3.53

7.09 × 10–04

5

CTGF

Connective tissue growth factor

3.49

1.55 × 10–04

6

CSTB

Cystatin

3.41

6.13 × 10–04

7

TSC22D3

Anti-inflammatory protein glucocorticoid (GC)-induced leucine zipper

3.36

3.94 × 10–04

8

DCN

Tumour suppressor gene

3.30

6.19 × 10–05

9

PTEN

Tumour suppressor gene

3.25

9.28 × 10–04

10

NF-κBIA

Inhibits the NF-κB transcription factor

3.24

1.06 × 10–04